sumatriptan has been researched along with Clerambault Syndrome in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Excerpt | Relevance | Reference |
---|---|---|
"The question whether symptom-free migraine patients show cognitive impairments compared to matched control subjects is addressed, and also whether migraine patients show transient cognitive impairments induced by an attack." | 1.30 | Interictal and postictal cognitive changes in migraine. ( de Geus, EJ; Linssen, WH; Mulder, EJ; Orlebeke, JF; Passchier, J, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mulder, EJ | 1 |
Linssen, WH | 1 |
Passchier, J | 1 |
Orlebeke, JF | 1 |
de Geus, EJ | 1 |
1 other study available for sumatriptan and Clerambault Syndrome
Article | Year |
---|---|
Interictal and postictal cognitive changes in migraine.
Topics: Adult; Attention; Cognition Disorders; Female; Humans; Male; Migraine Disorders; Neurocognitive Diso | 1999 |